Chemomab Therapeutics Ltd ADR (NQ: CMMB )
1.400
+0.180
(+14.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Chemomab Therapeutics Ltd ADR
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/07/25/CMMB.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://ml.globenewswire.com/media/07e28ce3-bf66-48fd-a935-293d63b15b7e/small/logo-1-1-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/CMMB.png?width=1200&height=800&fit=crop)
What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?
February 20, 2024
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/images/story/2024/01/18/image45.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://investorplace.com/wp-content/uploads/2014/06/investorplace-logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.